In addition, we found a downregulating trend in the transcriptomic data of NSCLC, although the overexpression of HSP90AA1, CDK2, and E2F1 was important for the proliferation of multiple tumors [29, 31, 41]. The gene discussed is CDK2; the disease is non-small cell lung carcinoma.